IL‐7–Mediated IL‐7R‐JAK3/STAT5 signalling pathway contributes to chemotherapeutic sensitivity in non–small‐cell lung cancer

OBJECTIVES: The chemotherapy drug resistance is a major challenge for non‐small‐cell lung cancer (NSCLC) treatment. Combination of immunotherapy and chemotherapy has shown promise for cancer. The goal of this study was to evaluate the anti‐tumour efficacy of interleukin‐7 (IL‐7) combining cisplatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Lin, Xu, Zhaozhong, Yang, Qiong, Huang, Yuanyuan, Gong, Yuxin, Wang, Fang, Ke, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6869130/
https://www.ncbi.nlm.nih.gov/pubmed/31599032
http://dx.doi.org/10.1111/cpr.12699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6869130/
https://www.ncbi.nlm.nih.gov/pubmed/31599032
http://dx.doi.org/10.1111/cpr.12699

Ejemplares similares